Navigation Links
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine Comes to the App Store
Date:8/3/2011

PHILADELPHIA, August 3, 2011 /PRNewswire/ --


- Content From the Widely-respected Cardiology Reference Book's Forthcoming Ninth Edition Now Available to Users on iPad, iPhone and iPod Touch


Elsevier, the leading provider of scientific, technical and medical information products and services, announced its Braunwald's Heart Disease Practice Guides App for iPad, iPhone and iPod Touch is now available on the App Store. The app includes content from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Ninth Edition, and provides the most up-to-date, evidence-based cardiology clinical practice guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA).

Braunwald's Heart Disease Practice Guidelines App provides access to the most useful, clinically actionable and evidence-based cardiology clinical practice guidelines today. The joint cardiovascular practice guidelines of the ACC and the AHA have become important documents for guiding cardiology practice and establishing benchmarks for quality of care. In each edition of Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, the market-leading global clinical textbook of cardiology, authors and editors summarize all the latest ACC/AHA practice guidelines and transform them into clinically actionable points presented in an easily accessible, bulleted format. For the first time the guidelines have been streamlined for mobile presentation and are available for download by cardiologists and all related healthcare professionals who want mobile access to this clinically actionable information in a high-yield, bulleted format.

"We wanted to provide cardiologists and healthcare professionals the ability to have the most up-to-date information available right at their fingertips," said Dr. Eugene Braunwald, founding editor and online editor of Braunwald's Heart Disease.  "This app will give clinicians and professionals anytime, anywhere access to this important information so they can continue to provide the best quality of care possible for their patients."

Braunwald's Heart Disease Practice Guidelines App has several features, including:

  • Content from the brand-new, ninth edition of Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine;
  • Content and cases based on the latest published evidence;
  • Clinically actionable points presented in an easily-digested, bulleted format;
  • Easy navigation, searching and browsing options.


Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Ninth Edition features definitive, state-of-the-art answers covering every aspect of contemporary cardiology.  Edited by Drs. Robert Bonow, Douglas Mann, Douglas Zipes, and Peter Libby, the reference applies the most recent knowledge in molecular biology and genetics, imaging, pharmacology, interventional cardiology, electrophysiology, and much more. Additionally, the new edition features online content, including new dynamic cardiac imaging videos, heart sound recordings, and podcasts.

The Braunwald's Heart Disease Practice Guidelines App is available for $24.99 from the App Store on iPad, iPhone and iPod touch, or at http://www.itunes.com/appstore .

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


Media contact
Tom Reller
Vice President Global Corporate Relations, Elsevier
+1-212-462-1912
t.reller@elsevier.com




'/>"/>
SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare to Report Financial Results for Second Quarter of 2011
2. German Patient Surpasses 5 Years of Support on DuraHeart™ Left Ventricular Assist Device
3. TandemHeart Approved for Expanded Reimbursement
4. Cardiac Science Gains Japanese Regulatory Approval for Powerheart AED
5. CardioFocus HeartLight™ Endoscopic Ablation System Enables Treatment of Atrial Fibrillation: Live Case and Abstract Presented at EHRA EUROPACE 2011
6. New Study Shows Viability of Heart Pumps for Older Heart-Failure Patients
7. Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
8. Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation
9. CardioFocus HeartLight™ Endoscopic Ablation System to be Featured at EHRA EUROPACE 2011
10. Franciscan St. Francis Heart Center Surgeon Pioneers Use of Heart Valve Repair Ring
11. HeartWare to Present at the Wells Fargo 2011 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
Breaking Medicine Technology:
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
Breaking Medicine News(10 mins):